PharmaCyte Biotech, Inc. (PMCB) KPIs and segments

PMCBNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends April 30

Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 7/30

$0.40+0.00 (+0.75%)

Close on Nov 12, 2026Market cap $4.32MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive PharmaCyte Biotech's business

Coming soon

This tab will track the numbers specific to PharmaCyte Biotech's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?